Showing results (121-130 of 324) with videos related to

Sort By:
Pageof 33
Molecular and Cellular Biology|June 25, 1998
Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domainM W Frazier, X He, J Wang, et al.
Tumori|June 30, 1985
Accuracy of the double contrast enema in evaluation of the abdominal diffusion of ovarian carcinomaG Cozzi, L Balzarini, M Bellomi, et al.
Journal of Voice : Official Journal of the Voice Foundation|September 11, 2016
Laryngeal Cancer, HPV DNA vs E6/E7 mRNA Test: A Systematic ReviewMassimo Fusconi, Flaminia Campo, Andrea Gallo, et al.
International Journal of Environmental Research and Public Health|August 28, 2025
The Relationship Between Well-Being and MountainTherapy in Practitioners of Mental Health DepartmentsFiorella Lanfranchi, Elisa Zambetti, Alessandra Bigoni, et al.
BMJ (Clinical Research Ed.)|January 15, 2005
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort studyGianni Bonadonna, Angela Moliterni, Milvia Zambetti, et al.
Frontiers in Behavioral Neuroscience|April 26, 2021
Corrigendum: The Risky Closed Economy: A Holistic, Longitudinal Approach to Studying Fear and Anxiety in RodentsBryan P Schuessler, Peter R Zambetti, Kisho M Fukuoka, et al.
International Journal of Cancer|July 18, 2000
Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancerR Silvestrini, A Luisi, M Zambetti, et al.
Frontiers in Behavioral Neuroscience|November 16, 2020
The Risky Closed Economy: A Holistic, Longitudinal Approach to Studying Fear and Anxiety in RodentsBryan P Schuessler, Peter R Zambetti, Kisho M Kukuoka, et al.
Molecular and Cellular Endocrinology|March 21, 2016
IGF1-R inhibition and liposomal doxorubicin: Progress in preclinical evaluation for the treatment of adrenocortical carcinomaFelix Beuschlein, Judith Jakoby, Susanne Mentz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiationM Zambetti, A Moliterni, C Materazzo, et al.
Pageof 33